Graft-versus-host Disease Prophylaxis With Abatacept Reduces Severe Acute Graft-versus-host Disease in Allogeneic Hematopoietic Stem Cell Transplant for Beta-thalassemia Major With Busulfan, Fludarabine, and Thiotepa

Khandelwal Pooja; Yeh Rosa F.; Yu Louie; Lane Adam; Dandoy Christopher E.; El-Bietar Javier; Davies Stella M.; Grimley Michael S.

首页> 外文期刊>Transplantation: Official Journal of the Transplantation Society >Graft-versus-host Disease Prophylaxis With Abatacept Reduces Severe Acute Graft-versus-host Disease in Allogeneic Hematopoietic Stem Cell Transplant for Beta-thalassemia Major With Busulfan, Fludarabine, and Thiotepa

【24h】

Graft-versus-host Disease Prophylaxis With Abatacept Reduces Severe Acute Graft-versus-host Disease in Allogeneic Hematopoietic Stem Cell Transplant for Beta-thalassemia Major With Busulfan, Fludarabine, and Thiotepa

机译：与腺嘌呤血症血症血症血症干细胞移植术治疗对同种异体造血干细胞移植治疗严重急性移植物与宿主病的饲养腹膜疾病的预防会降低

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Background.

机译：出身背景

著录项

来源
《Transplantation: Official Journal of the Transplantation Society》 |2021年第4期|共6页
作者
Khandelwal Pooja; Yeh Rosa F.; Yu Louie; Lane Adam; Dandoy Christopher E.; El-Bietar Javier; Davies Stella M.; Grimley Michael S.;
展开▼
作者单位

Cincinnati Childrens Hosp Med Ctr Div Bone Marrow Transplant &

Immune Deficiency Cincinnati OH;

Seattle Canc Care Alliance Div Pharmacol Seattle WA USA;

Seattle Canc Care Alliance Div Pharmacol Seattle WA USA;

Cincinnati Childrens Hosp Med Ctr Div Bone Marrow Transplant &

Immune Deficiency Cincinnati OH;

Cincinnati Childrens Hosp Med Ctr Div Bone Marrow Transplant &

Immune Deficiency Cincinnati OH;

Cincinnati Childrens Hosp Med Ctr Div Bone Marrow Transplant &

Immune Deficiency Cincinnati OH;

Cincinnati Childrens Hosp Med Ctr Div Bone Marrow Transplant &

Immune Deficiency Cincinnati OH;

Cincinnati Childrens Hosp Med Ctr Div Bone Marrow Transplant &

Immune Deficiency Cincinnati OH;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类器官移植术;
关键词

相似文献

外文文献
中文文献
专利

1. Analyses of risk factors for intestinal acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation [J] . 燕法红中国医学文摘：内科学分册（英文版） . 2014,第001期
2. Comparison between two fludarabine-based reduced-intensity conditioning regimens before allogeneic hematopoietic stem-cell transplantation: fludarabine|[sol]|melphalan is associated with higher incidence of acute graft-versus-host disease and non-relapse mortality and lower incidence of relapse than fludarabine|[sol]|busulfan [J] . A Shimoni, I Hardan, N Shem-Tov, Leukemia . 2007,第10期

机译：同种异体造血干细胞移植前两种基于氟达拉滨的低强度调理方案的比较：氟达拉滨| [sol] |美法仑与急性移植物抗宿主病发病率高，非复发死亡率和复发率低相关氟达拉滨| [sol] |白消安
3. Single-Agent High-Dose Cyclophosphamide for Graft-versus-Host Disease Prophylaxis in Human Leukocyte Antigen–Matched Reduced-Intensity Peripheral Blood Stem Cell Transplantation Results in an Unacceptably High Rate of Severe Acute Graft-versus-Host Disease [J] . Kenneth F. Bradstockcorrespondenceemail, Ian Bilmon, John Kwan, Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation . 2015,第5期

机译：单剂大剂量环磷酰胺可预防人类白细胞抗原匹配的降低强度的外周血干细胞移植，从而预防严重的急性移植物抗宿主病率
4. The impact of graft-versus-host disease prophylaxis in reduced-intensity conditioning allogeneic stem cell transplant in acute myeloid leukemia: a study from the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation | Haematologica [J] . Marie Thérèse Rubio, Myriam Labopin, Didier Blaise, Haematologica . 2015,第5期

机译：预防移植物抗宿主病对降低强度条件的同种异体干细胞移植在急性髓性白血病中的影响：欧洲血液和骨髓移植小组急性白血病工作组的研究|血液学
5. Anti-Thymocyte-Globulin (ATG-Fresenius) for Prevention of Acute and Chronic Graft-versus-Host Disease in Pediatric and Adult Recipients of Unrelated Donor Bone Marrow Transplantation [C] . . 2006

机译：抗胸腺细胞球蛋白（ATG-Fresenius）预防无关供体骨髓移植的小儿和成年患者的急性和慢性移植物抗宿主病
6. Symptoms, Cytokines, and Quality of Life of Patients with Chronic Graft-versus-Host Disease following Allogeneic Hematopoietic Stem Cell Transplantation. [D] . Kelly, Debra Lynch. 2014

机译：异基因造血干细胞移植后慢性移植物抗宿主病患者的症状，细胞因子和生活质量。
7. Evaluation of risk for graft-versus-host disease in children who receive less than the full doses of mini-dose methotrexate for graft-versus-host disease prophylaxis in allogeneic hematopoietic stem cell transplantation [O] . Sook Kyung Yum, Hye-Yoon Choi, Jae Wook Lee, 2013

机译：对异基因造血干细胞移植中预防小剂量氨甲蝶呤剂量不足的儿童进行移植物抗宿主病风险评估
8. Comparison between two fludarabine-based reduced-intensity conditioning regimens before allogeneic hematopoietic stem-cell transplantation: fludarabine/melphalan is associated with higher incidence of acute graft-versus-host disease and non-relapse mortality and lower incidence of relapse than fludarabine/busulfan [O] . A Shimoni, I Hardan, N Shem-Tov, 2007

机译：同种异体造血干细胞移植前两种氟达拉滨的减少强度调理方案的比较：Fludarabine / Melphalan与急性移植物与宿主疾病的发病率较高，非复发性死亡率以及较低的复发发病率超过Fludarabine / Busulfan
9. Animal Models for the Prevention of Acute and Chronic Graft-versus-Host Disease [R] . Gallagher, M. T., Petz, L. D. 1984

机译：预防急性和慢性移植物抗宿主病的动物模型

Graft-versus-host Disease Prophylaxis With Abatacept Reduces Severe Acute Graft-versus-host Disease in Allogeneic Hematopoietic Stem Cell Transplant for Beta-thalassemia Major With Busulfan, Fludarabine, and Thiotepa

摘要

著录项

相似文献

相关主题

期刊订阅